首页> 外文期刊>Biochimica et Biophysica Acta. General Subjects >The role of nitric oxide in hemodynamic and metabolic alterations induced by prostaglandin F_(2a) in the perfused rat liver
【24h】

The role of nitric oxide in hemodynamic and metabolic alterations induced by prostaglandin F_(2a) in the perfused rat liver

机译:一氧化氮在灌注大鼠肝脏中前列腺素F_(2a)引起的血流动力学和代谢改变中的作用

获取原文
获取原文并翻译 | 示例
       

摘要

In the liver prastuglandin.s have been shown to be potent regulators of portal blood flow, carbohydrate metabolism and bile secretion. It is not known whether these effects represent a direct action of prostaglandins, and it has been suggested that nitric oxide (NO) might be a critical mediator for prostaglandin induced hepatic events. We have studied whether nitric oxide formation or inhibition alters the action of proslagkuulin Is,, (PG F2(I) in a single-pass liver perfusion model. The liver of untreated rats (constitutive NO-synthase) or after prelrealinent with endotoxin (inducible form of NO-synthase) was perfused at a constant pressure via the portal vein. Effluate were collected in l-tnin intervals and bile in 5-min intervals. In both groups the addition of PG F2n (10 /u.M) to the perfusate for 5 min resulted in a significant increase of glucose and lactate production, and in a significant decrease in portal blood flow ( — 0.56 ± 0.04 ml/g per min), in bile flow (—60.7%) and in bile acid release ( — 60.6%). Inhibition of NO synthase by adding A/°-monomethyl-i.-arginine (t.-NMMA, 100 /xM) to the perfusate did not affect any of the alterations induced by PG F,,,. Substitution of the endogenous substrate For the NO synthase i.-arginine (500 /iM) in the perfusate completely prevented the hemodynamic alterations induced by PG F2(, in endotoxin pretreated livers and limited the flow reduction (0.15 ±0.04 ml/g per min) in the untreated group. The substitution of L-arginine in the perfusate of endotoxin pretreated livers raised nitrite (from 1.5 ± 0.3 to 3,6 ± 0.7 nmol/g per min) and urea release (from 65 ± 25 to 294 ± 68 nmol/g per min), but had no effect on any of the other metabolic parameters and bile secretion. We conclude that PG Is,, increases glucose and lactate production in the perfused rat liver and decreases portal flow and bile secretion. The metabolic effects induced by PG F2(, appear to be independent of NO mediation and hemodynamic alterations. Portal flow alone can be influenced by endogenous NO formation.
机译:在肝脏中,普拉司他汀被证明是门脉血流,碳水化合物代谢和胆汁分泌的有效调节剂。尚不清楚这些作用是否代表前列腺素的直接作用,并且已经提出一氧化氮(NO)可能是前列腺素诱导的肝事件的关键介质。我们研究了一氧化氮的形成或抑制作用是否改变了单次肝脏灌注模型中前列腺素Is(PG F2(I)的作用。未经治疗的大鼠的肝脏(组成型NO合酶)或内毒素(诱导型)超敏后通过门静脉在恒定压力下进行灌注;每l次间隔收集一次流出液,每隔5分钟收集一次胆汁;两组均在灌注液中添加PG F2n(10 / uM) 5分钟导致葡萄糖和乳酸的产生显着增加,门脉血流量(-0.56±0.04 ml / g /分钟),胆汁流量(-60.7%)和胆汁酸释放(-60.6)显着下降。通过向灌注液中加入A /°-单甲基-i-精氨酸(t.-NMMA,100 / xM)来抑制NO合酶,不会影响PG F引起的任何改变。内源性底物对于灌注液中的NO合酶i-精氨酸(500 / iM)完全阻止了血流动力学改变PG F2(在内毒素预处理的肝脏中)引起的血流量降低,限制了未治疗组的血流减少(0.15±0.04 ml / g每分钟)。内毒素预处理的肝脏灌注液中的L-精氨酸的替代提高了亚硝酸盐(从每分钟每分钟1.5±0.3至3.6±0.7 nmol / g)和尿素的释放(每分钟从每分钟65±25至294±68 nmol) ,但对其他任何代谢参数和胆汁分泌均无影响。我们得出的结论是,PG Is可增加灌注大鼠肝脏中葡萄糖和乳酸的产生,并减少门脉血流和胆汁分泌。 PG F2()诱导的代谢作用似乎与NO介导和血液动力学改变无关,内源性NO的形成会单独影响门静脉血流。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号